Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023
Thu, October 12, 2023

Allison Bratzel Initiated (ABCL) at Buy and Held Target at $20 on, Oct 13th, 2023

Allison Bratzel of Piper Sandler, Initiated "AbCellera Biologics Inc." (ABCL) at Buy and Held Target at $20 on, Oct 13th, 2023.

Allison has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Allison's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Allison


  • Robert Wasserman of "Benchmark" Maintained at Strong Buy with Decreased Target to $12 on, Thursday, August 31st, 2023
  • Andrea Tan of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $24 on, Friday, August 4th, 2023